SP Accure Labs Private Limited — Cyclophosphamide Exporter Profile
Indian Pharmaceutical Exporter · #5 for Cyclophosphamide · $272.7K export value · DGFT Verified
SP Accure Labs Private Limited is the #5 Indian exporter of Cyclophosphamide with $272.7K in export value and 22 verified shipments. SP Accure Labs Private Limited holds a 1.4% market share in Cyclophosphamide exports across 5 countries. The company exports 14 pharmaceutical products worth $3.5M across 3 therapeutic categories.
SP Accure Labs Private Limited — Cyclophosphamide Export Profile: Buyers & Destinations
Where Does SP Accure Labs Private Limited Export Cyclophosphamide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| IRAN | $181.9K | 11 | 66.7% |
| CHILE | $48.0K | 1 | 17.6% |
| PERU | $31.4K | 6 | 11.5% |
| SRI LANKA | $5.8K | 2 | 2.1% |
| GUYANA | $5.5K | 2 | 2.0% |
SP Accure Labs Private Limited exports Cyclophosphamide to 5 countries. The largest destination is IRAN accounting for 66.7% of SP Accure Labs Private Limited's Cyclophosphamide shipments, followed by CHILE (17.6%) and PERU (11.5%). These destinations reflect SP Accure Labs Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cyclophosphamide from SP Accure Labs Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| HIRAD PHARMED UNIT | IRAN | $181.9K | 11 |
| COMERCIALIZADORA ALEFFARMA LTDA. | CHILE | $48.0K | 1 |
| CENTRO NACIONAL DE ABASTECIMIENTO D | PERU | $17.1K | 4 |
| LS MEDISURE PERU SAC | PERU | $10.0K | 1 |
| PHARMA ASSOCIATES | SRI LANKA | $5.8K | 2 |
| NEW GPC INC | GUYANA | $5.5K | 2 |
| CENTRO NACIONALDE ABASTECIMIENTO DE | PERU | $4.3K | 1 |
SP Accure Labs Private Limited supplies Cyclophosphamide to 7 buyers globally. The largest buyer is HIRAD PHARMED UNIT (IRAN), followed by COMERCIALIZADORA ALEFFARMA LTDA. (CHILE) and CENTRO NACIONAL DE ABASTECIMIENTO D (PERU). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cyclophosphamide Export Value and How Much Does SP Accure Labs Private Limited Contribute?
India exported $4.6M worth of Cyclophosphamide through 2,113 shipments from 259 suppliers to 114 countries, serving 518 buyers globally. SP Accure Labs Private Limited contributes $272.7K to this total, accounting for 1.4% of India's Cyclophosphamide exports. SP Accure Labs Private Limited ships Cyclophosphamide to 5 countries through 7 buyers.
What Is the Average Shipment Value for SP Accure Labs Private Limited's Cyclophosphamide Exports?
SP Accure Labs Private Limited's average Cyclophosphamide shipment value is $12.4K per consignment, based on 22 shipments totaling $272.7K. The largest destination is IRAN (66.7% of SP Accure Labs Private Limited's Cyclophosphamide exports).
How Does SP Accure Labs Private Limited Compare to Other Indian Cyclophosphamide Exporters?
SP Accure Labs Private Limited ranks #5 among 259 Indian Cyclophosphamide exporters with a 1.4% market share. The top 3 exporters are EUGIA PHARMA SPECIALITIES LIMITED ($1.1M), ALEMBIC PHARMACEUTICALS LIMITED ($850.4K), CIPLA LIMITED ($550.0K). SP Accure Labs Private Limited processed 22 shipments to 5 destination countries.
What Cyclophosphamide Formulations Does SP Accure Labs Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CYCLOPHOSPHAMIDE POWDER FOR SOLUTION FORINJECTION/INFUSION BP 500 MG PER VIAL | $86.6K | 6 |
| CYCLOPHOSPHAMIDE POWDER FOR SOLUTION FORINJECTION/INFUSION 1000 MG PER VIAL BP | $49.5K | 2 |
| CYCLO SPAL-P1000 (CYCLOPHOSPHAMIDE POWDER FOR SOLUTION FOR INJECTION/INFUSION BP1000 MG) | $48.0K | 1 |
| CYCLOPHOSPHAMIDE POWDER FOR SOLUTION FORINJECTION/INFUSION BP 200 MG PER VIAL | $45.9K | 3 |
| SPXAN 50 (CYCLOPHOSPHAMIDE FILM COATED T | $12.2K | 3 |
| SPXAN 50 (CYCLOPHOSPHAMIDE TABLETS USP 50 MG) BATCH NO- 24DCT01(ANTICANCER DRUGS:---CYCLOPHOSPHAMIDE) (1 CAPSULES=1 NOS) | $10.0K | 1 |
| SPXAN 50 CYCLOPHOSPHAMIDE FILM COATED T | $9.2K | 2 |
| CYCLOPHOSPHAMIDE POWDER FOR SOLUTION FOR | $5.8K | 2 |
| CYCLO SPAL-P 500 - (CYCLOPHOSPHAMIDE POWDER FOR SOLUTION FOR INJECTION /INFUSIONBP 500 MG/VIA) | $4.9K | 1 |
| SPXAN-T 50, (CYCLOPHOSPHAMIDE 50MG TABLETS) | $640 | 1 |
SP Accure Labs Private Limited exports 10 distinct Cyclophosphamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CYCLOPHOSPHAMIDE POWDER FOR SOLUTION FORINJECTION/INFUSION B with 6 shipments worth $86.6K.
How Does SP Accure Labs Private Limited Compare to Nearest Cyclophosphamide Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | CIPLA LIMITED | $550.0K | 11 | 1 | $50.0K |
| 4 | VENUS REMEDIES LIMITED | $492.4K | 13 | 5 | $37.9K |
| 5 | SP ACCURE LABS PRIVATE LIMITED ★ | $272.7K | 22 | 5 | $12.4K |
| 6 | GETWELL PHARMACEUTICALS | $241.8K | 94 | 9 | $2.6K |
| 7 | KWALITY PHARMACEUTICALS LIMITED | $235.6K | 19 | 4 | $12.4K |
SP Accure Labs Private Limited ranks #5 among 259 Indian Cyclophosphamide exporters. Average shipment value of $12.4K compared to the market average of $17.9K. The closest competitors by value are CIPLA LIMITED and VENUS REMEDIES LIMITED.
Which Indian Ports Ship Cyclophosphamide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 561 | 26.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 442 | 20.9% |
| DELHI AIR | 246 | 11.6% |
| DELHI AIR CARGO ACC (INDEL4) | 189 | 8.9% |
| Bombay Air | 154 | 7.3% |
| Delhi Air | 51 | 2.4% |
| Bombay Air Cargo | 51 | 2.4% |
| HYDERABAD AIR | 36 | 1.7% |
What Other Oncology Products Does SP Accure Labs Private Limited Export?
SP Accure Labs Private Limited also exports these oncology products. Each links to the detailed product page.
About SP Accure Labs Private Limited
SP Accure Labs Private Limited exports 14 products worth $3.5M. Beyond Cyclophosphamide, top products include Paclitaxel, Protein, Bortezomib, Pazopanib, Cisplatin. View the complete SP Accure Labs Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cyclophosphamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cyclophosphamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SP Accure Labs Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 22 individual customs records matching SP Accure Labs Private Limited exporting Cyclophosphamide, covering 10 formulations to 5 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 114+ countries, 518+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cyclophosphamide Export Data from SP Accure Labs Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SP Accure Labs Private Limited's Cyclophosphamide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SP Accure Labs Private Limited
Full Company Profile →
14 products · $3.5M total trade · 3 categories
Cyclophosphamide Stats
Company Overview
Top Products by SP Accure Labs Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SP Accure Labs Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cyclophosphamide. For current shipment-level data, contact TransData Nexus.